Pascal Biosciences acquires technology to treat leukemia from The University of New Mexico: UNM Newsroom

Pascal Biosciences Inc., a drug discovery and development company, announced recently that the company has executed an exclusive, worldwide license option agreement with STC.UNM, The University of New Mexico’s technology-transfer and economic-development

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia - Sharma - 2019 - Cancer Science - Wiley Online Library

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Topics Archives - Page 77 of 190 - Vista Partners LLCVista Partners LLC

Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications - Lei - 2020 - Advanced Functional Materials - Wiley Online Library

Topics Archives - Vista Partners LLCVista Partners LLC

Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)

Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers

Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications - Lei - 2020 - Advanced Functional Materials - Wiley Online Library

Science

Science

100k Terms

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia - Sharma - 2019 - Cancer Science - Wiley Online Library

Recognition and functional activation of the human IgA receptor (FcαRI) by C-reactive protein

Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications - Lei - 2020 - Advanced Functional Materials - Wiley Online Library

Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications - Lei - 2020 - Advanced Functional Materials - Wiley Online Library